You are here: Home / Courses / Jose de Leon: Training psychiatrists to think like pharmacologists / 23. Valproate Case 2: Safety / Michael Goldberg’s reply to Hector Warnes’ comment on his comment
Thursday, 29.10.2020

Michael Goldberg’s reply to Hector Warnes’ comment on his comment
Jose de Leon: Valproate Case 2 Study

 

I read Dr. Warnes brief comments on my commentary and have no specific comments.  However, a key point I made about reporting adverse reactions using the best data available in the proper way seems to have been left to others to consider as the Valproate data are clearly not presented well in the slides.

 

April 26, 2018